Tirzepatide, a recently popular weight-loss drug, is advised for individuals with certain cases of type 2 diabetes and obesity, according to Zuellig Pharma, a pharmaceutical company.
The drug, fondly known as “Tirz,” recently gained popularity due to its dual-action mechanism, which can help regulate both blood sugar and body weight.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
